136 related articles for article (PubMed ID: 19338011)
1. Oestrogenic activity of benzyl salicylate, benzyl benzoate and butylphenylmethylpropional (Lilial) in MCF7 human breast cancer cells in vitro.
Charles AK; Darbre PD
J Appl Toxicol; 2009 Jul; 29(5):422-34. PubMed ID: 19338011
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells.
Matsumura A; Ghosh A; Pope GS; Darbre PD
J Steroid Biochem Mol Biol; 2005 Apr; 94(5):431-43. PubMed ID: 15876408
[TBL] [Abstract][Full Text] [Related]
3. Oestrogenic and androgenic activity of triclosan in breast cancer cells.
Gee RH; Charles A; Taylor N; Darbre PD
J Appl Toxicol; 2008 Jan; 28(1):78-91. PubMed ID: 17992702
[TBL] [Abstract][Full Text] [Related]
4. Oestrogenic activity of benzylparaben.
Darbre PD; Byford JR; Shaw LE; Hall S; Coldham NG; Pope GS; Sauer MJ
J Appl Toxicol; 2003; 23(1):43-51. PubMed ID: 12518336
[TBL] [Abstract][Full Text] [Related]
5. Oestrogenic activity of isobutylparaben in vitro and in vivo.
Darbre PD; Byford JR; Shaw LE; Horton RA; Pope GS; Sauer MJ
J Appl Toxicol; 2002; 22(4):219-26. PubMed ID: 12210538
[TBL] [Abstract][Full Text] [Related]
6. Oestrogenic activity of p-hydroxybenzoic acid (common metabolite of paraben esters) and methylparaben in human breast cancer cell lines.
Pugazhendhi D; Pope GS; Darbre PD
J Appl Toxicol; 2005; 25(4):301-9. PubMed ID: 16021681
[TBL] [Abstract][Full Text] [Related]
7. Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells.
Murphy LC; Peng B; Lewis A; Davie JR; Leygue E; Kemp A; Ung K; Vendetti M; Shiu R
J Mol Endocrinol; 2005 Apr; 34(2):553-66. PubMed ID: 15821116
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the global gene expression profiles produced by methylparaben, n-butylparaben and 17beta-oestradiol in MCF7 human breast cancer cells.
Pugazhendhi D; Sadler AJ; Darbre PD
J Appl Toxicol; 2007; 27(1):67-77. PubMed ID: 17121429
[TBL] [Abstract][Full Text] [Related]
9. Enhanced formation of non-phenolic androgen metabolites with intrinsic oestrogen-like gene transactivation potency in human breast cancer cells: a distinctive metabolic pattern.
Pérez-Palacios G; Santillán R; García-Becerra R; Borja-Cacho E; Larrea F; Damián-Matsumura P; González L; Lemus AE
J Endocrinol; 2006 Sep; 190(3):805-18. PubMed ID: 17003281
[TBL] [Abstract][Full Text] [Related]
10. Selenium disrupts estrogen signaling by altering estrogen receptor expression and ligand binding in human breast cancer cells.
Lee SO; Nadiminty N; Wu XX; Lou W; Dong Y; Ip C; Onate SA; Gao AC
Cancer Res; 2005 Apr; 65(8):3487-92. PubMed ID: 15833885
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
Zhao C; Matthews J; Tujague M; Wan J; Ström A; Toresson G; Lam EW; Cheng G; Gustafsson JA; Dahlman-Wright K
Cancer Res; 2007 Apr; 67(8):3955-62. PubMed ID: 17440111
[TBL] [Abstract][Full Text] [Related]
12. Oestrogenic activity of parabens in MCF7 human breast cancer cells.
Byford JR; Shaw LE; Drew MG; Pope GS; Sauer MJ; Darbre PD
J Steroid Biochem Mol Biol; 2002 Jan; 80(1):49-60. PubMed ID: 11867263
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
14. Transactivation of ERalpha by Rosiglitazone induces proliferation in breast cancer cells.
Talbert DR; Allred CD; Zaytseva YY; Kilgore MW
Breast Cancer Res Treat; 2008 Mar; 108(1):23-33. PubMed ID: 17453334
[TBL] [Abstract][Full Text] [Related]
15. Melatonin inhibits both ER alpha activation and breast cancer cell proliferation induced by a metalloestrogen, cadmium.
Martínez-Campa C; Alonso-González C; Mediavilla MD; Cos S; González A; Ramos S; Sánchez-Barceló EJ
J Pineal Res; 2006 May; 40(4):291-6. PubMed ID: 16635015
[TBL] [Abstract][Full Text] [Related]
16. Proliferative responses to altered 17beta-hydroxysteroid dehydrogenase (17HSD) type 2 expression in human breast cancer cells are dependent on endogenous expression of 17HSD type 1 and the oestradiol receptors.
Jansson A; Gunnarsson C; Stål O
Endocr Relat Cancer; 2006 Sep; 13(3):875-84. PubMed ID: 16954436
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
[TBL] [Abstract][Full Text] [Related]
18. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of transcriptional activity of the oestrogen receptor with sodium iodide symporter as an imaging reporter gene.
Kang JH; Chung JK; Lee YJ; Kim KI; Jeong JM; Lee DS; Lee MC
Nucl Med Commun; 2006 Oct; 27(10):773-7. PubMed ID: 16969258
[TBL] [Abstract][Full Text] [Related]
20. Changes in oestrogen receptor-alpha and -beta during progression to acquired resistance to tamoxifen and fulvestrant (Faslodex, ICI 182,780) in MCF7 human breast cancer cells.
Shaw LE; Sadler AJ; Pugazhendhi D; Darbre PD
J Steroid Biochem Mol Biol; 2006 Apr; 99(1):19-32. PubMed ID: 16533599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]